ACM
PTX

Argent Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Argent Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-27,030
Closed -$976K – 160
2013
Q2 		$976K Buy
+27,030
New +$1.01M 0.06% 128

Other funds holding PTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Argent Capital Management's PTX Position: Q3 2013 in Review

Argent Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2013, closing a stake of 27,030 shares — an estimated $976K sold.

Argent Capital Management first reported a position in PTX in Q2 2013 and held it in 1 quarter. The position peaked at $976K in Q2 2013. 45 funds tracked by Wall St. Rank hold PTX as of Q3 2013.

  • Argent Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2013 after selling out during the quarter.
  • Argent Capital Management sold 27,030 Pernix Therapeutics Holdings, Inc. shares in Q3 2013, an estimated $976K.
  • Argent Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 1 quarter.
  • Argent Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $976K in Q2 2013.
  • 45 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2013.

Based on Argent Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.